Saturday 17 October 2026
Export TLPH’s income statement to Excel — free account
Talphera, Inc.
TLPH Healthcare Drug Manufacturers Specialty & Generic
In the quarter to June 2026, revenue fell 99.6%, EPS grew 40.0% and free cash flow fell 33.1%, each against the same quarter a year earlier. Operating cash flow growth for five consecutive years; insiders bought in the last twelve months.
1.08
0.01
+0.93%
Follow TLPH
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (143.36%) | (118.40%) | (114.16%) | (85.97%) |
+8 more TTM periods Free account |
|
| (69.60%) | (63.14%) | (59.60%) | (47.87%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(109.25%) | (82.33%) | (83.61%) | (66.21%) | |
Average Days of Receivables |
— | — | — | 0.00 | |
Free Cash Flow per Share |
(0.16) | (0.16) | (0.27) | (0.27) | |
Free Cash Flow |
(12.27) | (11.29) | (11.36) | (11.18) | |
| Other line items | |||||
Cash ROIC |
(38.97%) | (28.53%) | (30.37%) | (27.63%) | |
Accounts Receivable Turnover |
— | — | — | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 1,360.33% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 1,704.23% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 174.65% | |
Operating CF/Net income |
0.81 | 0.79 | 0.80 | 0.90 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.01 | |
Operating CF per Share |
(0.16) | (0.16) | (0.27) | (0.27) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
— | — | — | 0.00 |
Columns are period end dates